This session dives into the evolving field of tumors with myogenic differentiation, including rhabdomyogenic tumors, pericytic tumors, and unclassified sarcomas with myogenic differentiation, and aims to improve recognition of unusual entities in this spectrum. A particular focus is to enable improved discrimination of true leiomyosarcoma from benign and malignant mimics.